Medicare publishes prices for the first 10 drugs subject to negotiations

Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…

What Wall Street is watching

Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…

Fund manager of names in weight loss and biotechnology

Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…